38 results about "Disodium Hydrogen Citrate" patented technology

The invention relates to a medicinal composition containing a meglumine cyclic adenosine monophosphate compound, and in particular relates to freeze-dried injection of meglumine cyclic adenosine monophosphate and a preparation method thereof. Each 1,000 injections are prepared from the following components: 20g of meglumine cyclic adenosine monophosphate, 100 to 200g of mannitol, 1 to 3g of ethylene diamine tetraacetic acid (EDTA) calcium, 1 to 2g of vitamin C, and 2,000ml of a buffer solution of disodium hydrogen citrate and trisodium citrate at a mole ratio of 1: 4.

The invention relates to a pharmaceutical composition containing a nalmefene hydrochloride compound. For every 1000 injections, the pharmaceutical composition comprises the following components: 100mg of nalmefene hydrochloride, 1-2g of Tween 80, 1-3g of EDTA (Ethylene Diamine Tetraacetic Acid) calcium, 1-2g of vitamin C, 1000ml of sodium hydrogencitrate and trisodium citrate buffer liquor with molar ratio of 1:4, and the balance of water for injection.

The invention relates to a pharmaceutical composition containing a granisetron hydrochloride compound, and in particular to a freeze-dried injection preparation of granisetron hydrochloride and a preparation method thereof. For every 1000 injections, the pharmaceutical composition comprises the following components: 3g of granisetron hydrochloride, 100-200g of mannitol, 1-3g of sodium hydroxide, 1-2g of vitamin C, and 2000ml of sodium hydrogencitrate and trisodium citrate buffer liquor with molar ratio of 1:4.

The invention relates to a medicinal composition containing a lysine hydrochloride compound, and in particular relates to freeze-dried injection of lysine hydrochloride and a preparation method thereof. Each 1,000 injections are prepared from the following components: 3,000g of lysine hydrochloride, 100 to 200g of mannitol, 1 to 3g of ethylene diamine tetraacetic acid (EDTA) calcium, 1 to 2g of vitamin C, and 2,000ml of buffer solution of disodium hydrogen citrate and trisodium citrate in a mole ratio of 1:4.

The invention relates to medical preparations, in particular to a flexible hydrosol auxiliary agent for ophthalmology, which consists of: 0.2% to 0.5% of disodium hydrogen citrate, 1% to 1.5% of monosodium hydrogen citrate, and hydroxypropyl methylcellulose 5%~8%, sodium chondroitin sulfate 0.5%~1%, potassium chloride 0.5%~2%, magnesium chloride 0.3%~0.8%, sodium acetate 0.3%~1.5%, sodium chloride 1.3%~2.5%, no Bacteria double distilled water 85 ~ 90%. There can also be sodium hyaluronate 1% to 3%. The present invention is under the premise of ensuring the performance of the product, reducing the risk of nucleation and deposition, and slowing down the turbidity of the lens. Significantly reduced the consumption of disodium hydrogen citrate and magnesium chloride. It reduces the irritation to the patient's eyes, and avoids complications such as itching, tearing, redness and swelling in the patient's eyes. At the same time, the bionic level of the preparation is improved. The stability of the preparation is significantly improved, and it is suitable for long-term use, and has good effects as eye care, anti-dryness and anti-fatigue.

The invention belongs to the field of detection of pesticide residues and relates to a method for extracting and purifying hymexazol pesticide residues in a tobacco sample, a method for detecting hymexazol pesticide residues and a composition or a kit for extracting and purifying hymexazol or detecting hymexazol. Specifically, the method for extracting and purifying the hymexazol pesticide residues in the tobacco sample comprises the following steps: (1) soaking the tobacco sample in an alkaline solution, adding ethyl acetate and oscillating to obtain a primary extraction solution; and (2) mixing the obtained primary extraction solution with any one of reagent groups A-C, standing the mixture, and extracting a supernatant solution 1, wherein the reagent group A comprises magnesium sulfate and sodium chloride, the reagent group B comprises magnesium sulfate, sodium chloride, sodium citrate and disodium hydrogen citrate sesquihydrate, and the reagent group C comprises magnesium sulfate, sodium acetate trihydrate and acetic acid. The method for extracting and purifying the hymexazol pesticide residues in the tobacco sample is high in hymexazol extraction rate, small in pollution and low in cost.